| Colorectal Cancer |
1 |
1 |
| Antineoplastic Drug |
0 |
0.99 |
| Biologic Therapy |
0 |
0.92 |
| Breast Cancer |
0 |
0.88 |
| Cancer |
0 |
0.77 |
| HER2-Positive Breast Cancer |
0 |
0.98 |
| Humanized Monoclonal Antibody |
0 |
0.47 |
| Breast |
0 |
0.23 |
| Abdominal Pain |
0 |
0.2 |
| Grant |
0 |
0.18 |
| Pain Management |
0 |
0.18 |
| Abdomen |
0 |
0.12 |
| Aminotransferase |
0 |
0.12 |
| Chemotherapy |
0 |
0.12 |
| Pain |
0 |
0.12 |
| Microsatellite Instability-High |
0 |
0.08 |
| Clinical Research |
0 |
0.06 |
| Fatigue |
0 |
0.06 |
| Fever |
0 |
0.06 |
| Hemoglobin |
0 |
0.06 |
| Lymphocytes |
0 |
0.06 |
| Microsatellite Instability |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Tumor |
0 |
0.06 |
| Vascular Endothelial Growth Factor |
0 |
0.06 |
| Diarrhea |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Pneumonia |
0 |
0.05 |
| Urinary Tract Infection |
0 |
0.05 |